Elanor Commercial Property Fund

ECF

Elanor Commercial Property Fund is a real estate investment trust. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-12-06. The Fund’s investment property portfolio comprised nine commercial properties in Australia. The Fund’s objective is to provide risk-adjusted returns through a combination of regular distributions and capital growth. The Fund’s investment strategy includes investing in commercial office properties located in metropolitan areas or established commercial precincts; implement leasing and active asset management to grow the income and value of the properties; acquiring additional investment grade commercial properties; and maintain a conservative capital structure with a target Gearing range between 30% and 40%. The firm is managed by Elanor Funds Management Limited.

Echelon Resources Limited

ECH

New Zealand Oil & Gas Ltd. engages in the production and exploration of crude oil, natural gas, liquefied petroleum gas, and light oil. Its segments include Perth Basin, Kupe oil & gas field (Kupe), Amadeus Basin oil & gas fields, and Cue Energy Resources Limited (Cue). Perth Basin segment is engaged in exploration interests in Western Australia comprising the L7 Production license and EP437 Exploration Permit. Kupe segment is engaged in the development, production, and sale of natural gas, liquified petroleum gas and condensate (light oil), located in the offshore Taranaki Basin, New Zealand. Amadeus Basin oil & gas fields segment includes Mereenie oil and gas field, Palm Valley gas field and Dingo gas field, all located in the Amadeus Basin in Australia. Cue segment includes its participating interest in the Amadeus Basin assets. The 5,600-square kilometer Mahato PSC is located in the Central Sumatra basin close to several producing oil fields. The Mahato PSC covers a prospective area, close to several large producing oil fields.

Ebos Group Limited

EBO

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. The company sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.

EBR Systems Inc.

EBR

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. The company is headquartered in Sunnyvale, California. The company went IPO on 2021-11-24. The firm is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The firm also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The firm operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.